Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The osmotic gradient in tissue refers to the difference in solute concentration across a semipermeable barrier, usually a cell membrane or tissue interface. This gradient determines the *direction and extent of water movement* via osmosis, where water flows from areas of low solute concentration (higher water potential) to areas of high solute concentration (lower water potential). In biological systems, osmotic gradients underlie critical processes such as cellular hydration, tissue fluid balance, and the dynamic regulation of cell volume. Disruption or rapid shifts in these gradients contribute to tissue injury, edema, and can complicate therapy (such as rapid sodium correction or dehydration). This is a physicochemical property relevant to tissue physiology, rather than a distinct molecular entity.
None directly (but drugs like mannitol or hypertonic saline increase extracellular osmolarity to draw water out of tissues via osmotic gradients)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Osmotic gradient in tissue.